Ad
related to: massar identification tool for cancer
Search results
Results From The WOW.Com Content Network
Serge Massar was born in Zambia in 1970. [2] He obtained a degree in physics, then a PhD from the Université libre de Bruxelles (ULB) in 1991 and 1995, respectively. [2] He completed his post-doctoral research at Tel Aviv University from 1995 to 1997, and subsequently at Utrecht University from 1997 to 1998. [2] [3]
Tumor marker. A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers (measure progression or response to therapy). They can be found in bodily fluids or tissue. Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response ...
Since 2015 Maus has worked in the Massachusetts General Hospital and Dana–Farber Cancer Institute. Here she leads the Cellular Immunotherapy Program which translates her research into clinical trials for patients with malignancies. Maus develops chimeric antigen receptor (CAR)-T cells for cancer patients.
Molecular diagnostics. Specialist using "QIAsymphony", an automation platform for molecular diagnostic tests. Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing.
In the United States, head and neck cancer makes up 3% of all cancer cases (averaging 53,000 new diagnoses per year) and 1.5% of cancer deaths. The 2017 worldwide figure cites head and neck cancers as representing 5.3% of all cancers (not including non-melanoma skin cancers).
Mascot is a software search engine that uses mass spectrometry data to identify proteins from peptide sequence databases. Mascot is widely used by research facilities around the world. Mascot uses a probabilistic scoring algorithm for protein identification that was adapted from the MOWSE algorithm.
Cancer cell identification and classification Cancer cells can be classified by identifying MicroRNA expression. [2] These mRNA expression levels can be used as a diagnostic and prognostic tool in tumor and cancer classifications, although current tumor classification methods do not incorporate experimental knowledge. [2]
Lin has used the EMBRACE (Ending Metastatic Breast Cancer for Everyone) database, which contains information from several thousand metastatic breast cancer patients. She sequenced almost 800 tumor samples. These investigations will help to identify genomic predictors of breast cancer related metastases.
Ad
related to: massar identification tool for cancer